4//SEC Filing
Balthaser Kevin 4
Accession 0001415889-25-000623
CIK 0001557746other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:25 PM ET
Size
21.9 KB
Accession
0001415889-25-000623
Insider Transaction Report
Form 4
Balthaser Kevin
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-12-31$2.48/sh−30,732$76,215→ 67,715 total - Award
Restricted Stock Units
2025-01-02+40,000→ 40,000 total→ Common Stock (40,000 underlying) - Tax Payment
Common Stock
2025-01-01$2.48/sh−2,430$6,026→ 72,785 total - Exercise/Conversion
Common Stock
2024-12-31+73,750→ 98,447 total - Exercise/Conversion
Common Stock
2025-01-01+7,500→ 75,215 total - Exercise/Conversion
Common Stock
2025-01-02+13,200→ 85,985 total - Exercise/Conversion
Restricted Stock Units
2025-01-01−7,500→ 15,000 total→ Common Stock (7,500 underlying) - Tax Payment
Common Stock
2025-01-02$2.48/sh−5,059$12,546→ 80,926 total - Exercise/Conversion
Restricted Stock Units
2024-12-31−73,750→ 73,750 total→ Common Stock (73,750 underlying) - Exercise/Conversion
Restricted Stock Units
2025-01-02−13,200→ 26,800 total→ Common Stock (13,200 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
- [F3]50% of the shares underlying these restricted stock units vested or will vest on each of December 31, 2024 and December 31, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
- [F4]On February 1, 2023, the Reporting Person was granted 30,000 restricted stock units. The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of January 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date.
- [F5]The shares underlying these restricted stock units vest as to 33% on January 2, 2025, 33% on January 2, 2026, and 34% on January 2, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001957554
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:25 PM ET
- Size
- 21.9 KB